Understanding the Burden of Alzheimer’s & Mild Cognitive Impairment (MCI) in the UK
Understanding the Burden of Alzheimer's & Mild Cognitive Impairment (MCI) in the UK
Partner: Certara UK (Global Biopharma)
CHALLENGE
- Needed robust data on AD and MCI burden
- Required high-quality datasets for independent analysis
OUR APPROACH
- Access via Akrivia’s RLDA platform (UK largest mental health dataset)
- Curated tailored dataset and secured analytics environment
- Provided R&D and technical support
OUTCOMES
- Delivered real-world evidence on AD and MCI burden
- Enabled independent, in-depth analysis by Certara’s team
IMPACT
- Greater confidence in client recommendations
- Supported evidence-based decision-making on AD and MCI